RxDoctor Payments Data

Lisa Greer, APRN

Family · Waterville, OHNPI 1528722857

Payments from drug & device makers

$3,711in general payments, 2019–2025

Across 211 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$437
  • AbbVie$341
  • Novo Nordisk$326
  • Lundbeck LLC$279
  • Boehringer Ingelheim$245
  • GSK$232
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$3,711100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,711 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$40,179
Medicare patients
323
Services billed
635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PaxlovidNirmatrelvir/Ritonavir16$5,625
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl21$1,296
Albuterol Sulfate HfaAlbuterol Sulfate16$406
Azithromycin83$392
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst37$270
Trazodone Hcl17$261
Omeprazole14$189
Gabapentin25$160
Methylprednisolone28$139
Cyclobenzaprine Hcl17$129
Prednisone46$128
Levothyroxine Sodium12$122
Amlodipine Besylate16$119
Potassium Chloride11$117
Atorvastatin Calcium18$113

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$128$5,62516 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$21$12212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,812 family providers in Ohio.

Other family in Waterville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →